INTRODUCTION
Central venous access devices (CVADs), including peripherally inserted central catheters (PICCs), are required to provide vascular access for the majority of critical care patients to deliver intravenous (IV) fluids and medications, and for haemodynamic monitoring. The goal is for CVADs to be used until the end of the required treatment, without complications that restrict/prevent device use, or trigger device removal and insertion of a replacement device. Such complications can be mechanical (for example, blockage, dislodgement, vein thrombosis, CVAD rupture), or infective (for example, local or bloodstream infections) 1 . Such device failures reduce patient satisfaction, prolong hospitalisation, increase health care costs and impact mortality [2] [3] [4] .
The incidence of CVAD failure and complications is unacceptably high. A systematic review of paediatric and neonatal CVADs reported that 25% failed before the completion of therapy 1 . While there is no comparable systematic review of total CVAD complications in adults, a review of central line-associated bloodstream infection (CLABSI) in the adult intensive care unit (ICU) reported a median incidence of 5.7 per 1000 catheter days 5 . Observational studies in adult critical care settings have reported that catheter-related bloodstream infection (CRBSI) (that is to say, CVAD is the definitive source) occurs in 2.8-3.0%, and thrombosis in 1.0-8.4% of CVADs 6, 7 . A systematic review highlighted a higher incidence of thromboembolism in PICCs in the critical care population compared to hospitalised patients on general wards (13.9%, 95% CI 7.7-20.1% vs 4.9%, 95% CI 4.1-5.6%) 8 .
Clinical quality registries capture routine clinical practice outside controlled research conditions and therefore play a vital role in monitoring disease and health care delivery patterns, by providing treatment and service outcomes to clinicians, educators and policy-makers 9 . Recently, registries have also been used to provide comparative benchmarking of facilities, to allow improvements in health care processes, monitor adherence to clinical practice guidelines and standards, and assess the cost-effectiveness of delivered interventions [9] [10] [11] [12] [13] . Examples of such registries that currently exist are for stroke, acute myocardial syndrome, heart failure and renal failure and these have resulted in quality improvements in clinical settings 12,14-16 . However, existing registries capture only part of the health care system, resulting in significant gaps in knowledge about therapeutic effectiveness in many clinical areas 17 . Several studies have highlighted discrepancies between the clinical outcomes obtained during controlled research trial studies and those observed in routine clinical practice, confirming the need for ongoing registry monitoring 18, 19 . Recently, a national http://journals.cambridgepublishing.com.au/sports_journal/Subscribers/Past_Issues/Read_Article?id=735&i=81 2/9 arrangement for clinical quality registries was indicated and recommended by the Australian Commission on Safety and Quality in Health Care (ACSQHC) for quality improvement in health care settings 17 .
Despite this recommendation, the only consistently collected CVAD data are on BSI associated with haemodialysis catheters reported by the Australian Council on Healthcare Standards (ACHS) 20 and CLABSI reported via the Australian and New Zealand Intensive Care Society CLABSI registry (http://www.anzics.com.au/Pages/CLABSI.aspx) 21, 22 . There is no comparable national registry data relating to any mechanical CVAD failures in Australia. In contrast, a vast amount of CVAD data is contained at an individual hospital level within patient records; for example, electronic medical records (EMR), such as Metavision (iMDsoft Australia), are used in multiple ICUs across Australia, and potentially could be harnessed for a registry that facilitates research and quality assessment purposes 23 . However, the Metavision EMR used in our ICU is not yet structured to assess for specific CVAD outcomes including device failures. It is also unable to calculate CVAD days and CVAD failure per 1000 catheter days, which are important when benchmarking outcomes, both internally and externally. To become useful and accepted for registry use, a data pathway must: (1) be set up from the point of care entry (into EMR); (2) extract data to a registry; and (3) generate reports of close to real-time CVAD information and outcomes. The primary aim of this study was to examine the feasibility of establishing and maintaining a CVAD registry to measure device outcomes for adult patients with PICCs inserted in ICU.
METHODS
This study used 12 months' retrospective data (1 April 2016 to 31 March 2017) of all patients who had a PICC inserted while receiving care at a 24-bed ICU in a tertiaryreferral hospital in Australia. A list of patients with PICCs was automatically generated in Metavision by querying the 'devices' field of the EMR (see Appendix 1) . The report also included PICCs that were inserted outside ICU and PICCs from previous admissions; however, these PICCs were excluded to ensure eligible PICCs were captured only once upon insertion, and not re-collected on subsequent admissions. Information was collected on this patient cohort until the following endpoints were reached: removal of PICC, patient transfer to another hospital/facility, or death. Information was gathered primarily from Metavision, and then from paper charts if patients were discharged from ICU with the PICC in situ. Baseline data (patient demographic and PICC details) and information on PICC complications and failures were entered into the registry using the data management system Research Electronic Data Capture (REDCap, Vanderbilt University, USA). Laboratory data from the hospital electronic pathology system was accessed to obtain information regarding positive blood and /or other cultures to ascertain whether the PICC had a local infection or CLABSI. Confirmed CLABSI data was obtained from the hospital Infection Management and Prevention Service. 
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Primary outcomes
The primary outcome was registry feasibility as defined by the ACSQHC feasibility criteria for Clinical Quality Registries 17 : (i) consistency (in identifying PICC failure); (ii) governance (by meeting the requirements at the study site to establish a registry); (iii) operational requirements (sufficient resources obtained to maintain a registry); (iv) scope (capturing the entire eligible population); (v) capture of necessary data; (vi) clinically meaningful indicators (validated data collection tools); and (vii) infrastructure (ability of clinical information system to support data collection and reporting) 17 .
Secondary outcomes
The secondary outcomes were: PICC utilisation ratio; PICC numbers and days (dwell-time); demographics of patients and PICC details (age, gender, weight, dwell time, primary diagnosis, CVADs in situ at time of PICC insertion, use of vesicants, insertion bundle checklist used, insertion side, insertion complications, laboratory-confirmed infection within 48 hours prior to insertion, number of lumens); reason for removal; and PICC failure per 1000 catheter days (CLABSI, occlusion, catheter-related thrombosis, migration, dislodgement, and PICC rupture).
Analysis
Statistical analysis was performed using Stata 12.1 (Stata Corp, College Station, Texas, USA). The PICC utilisation ratio was calculated by dividing the number of PICCs by the number of total patient days of all ICU patients during the data collection period 24 . The two-by-two contingency table was used to show the demographics of patients and PICC details by failed PICCs versus non-failed PICCs to generate hypotheses for future research. Continuous variables were expressed as mean and standard deviation. Categorical data were expressed as numbers and percentages. The incidence rate was calculated by failure/complication divided by CVAD days and multiplying the result by 1000 24 .
RESULTS
Feasibility outcomes
The registry met the feasibility criteria with the exception of criteria 3 (operational requirement), criteria 5 (capturing necessary data), and criteria 7 (infrastructure). About half of all patients were transferred to a hospital ward with their PICC in situ. The clinical information system at the study site did not use an EMR for the surgical/medica wards, resulting in the research nurse hand-searching and reviewing paper medical records to obtain follow-up data post ICU-discharge. Thus, where EMRs were unavailable, the PICC removal data were difficult and time-consuming to obtain. Twenty-two per cent of PICC entries were lost to follow-up due to the unavailability of paper charts (missing or in use by other clinicians and/or researchers). As a result, we found it was not sustainable to maintain a PICC registry reliant on manual data entry without a hospital-wide EMR. However, if only used to capture insertion data, the registry successfully met six out of seven criteria, failing only criteria 3 (operational requirement) as all insertion data were available on the EMR. Moreover, the operational requirement could be met if the registry questions were built into the routine EMR data collection, entered by clinicians, and then auto-populated to the registry. See PICC utilisation ratio, catheter numbers and days
The total length of stay of all ICU patient was 6,424 days from 1,820 ICU admissions during the study period. There were 280 PICCs inserted in 225 patients that accounted for a total of 3,000 catheter days. The PICC utilisation ratio was 0.467. All PICCs (100%) were inserted by medical staff using ultrasound guidance for vessel imaging and chest x-ray to confirm tip position. Only one PICC (< 1%) was inserted using a guidewire exchange.
Demographics of patients requiring PICC, and PICC details
A summary of the study population demographics and PICC details are listed in Table 2 . Multiple indications for use could be selected for each PICC on the registry. PICCs were clinically indicated for the type of IV treatment (99%), which included vesicants (91%) and prolonged treatment (99%). Triple lumen PICCs were most frequently used as per clinician preference (88.9%). 
DISCUSSION
This registry successfully collected information about patients requiring PICCs, including indication for PICCs and characteristics of PICC, when using ICU information available on the EMR, and with minimal additional time to add CLABSI outcomes from the routine data collected by the hospital. However, the registry was unable to collect information on complications and reasons for removal for the sub-group that switched from the EMR to paper charts upon ICU discharge. Insufficient information technology infrastructure resulted in 22% of data being lost to follow-up. The CLABSI rate (0.33 per 1000 days) was lower than a previous meta-analysis of PICC-related CLABSI (1.0-2.1 per 1000 catheter days) 26 and slightly lower than previously published registry data (0.44/1,000 days) from 2015-2016 22 . A previous pilot RCT conducted at the same facility reported no CLABSI or local infection 27 , which supports this low CLABSI rate. It was also revealed that 33 PICCs were removed due to suspected catheter infection compared with only one confirmed CLABSI, suggesting that a significant number of PICCs were removed unnecessarily or that diagnostic approaches were not adequate. This is similar to previous studies 28, 29 ; for example, in the prospective cohort study by Parienti et al. 29 , of 2532 catheters studied, 310 were removed for suspected CLABSI but only 26 were confirmed as catheter-related infection. Previous studies have investigated the effects of immediate, deferred or no removal of CVADs suspected of infection and found no difference in morbidity or mortality between groups 30, 31 . The current clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection recommends that long-term catheters should be removed from patients with CRBSI with any conditions such as severe sepsis, suppurative thrombophlebitis, endocarditis, BSI that persists for longer than 72 hours despite antimicrobial therapy, or infection due to Staphylococcus aureus, Pseudomonas aeruginosa, fungi, or mycobacteria 32 . It is also recommended that patients with CRBSI originating from a short-term catheter (as a result of a gram-negative bacilli, S. aureus, enterococci, fungi, and mycobacteria) should have their device immediately removed 32 . However, it is questionable if this guideline is also applicable for ICU patients who are often in an unstable condition. A clear guideline for the management of CVADs suspected of infection for ICU patients is urgently needed to prevent unnecessary removal of CVADs and the associated increased risks to patients and costs to the health care system.
In a recent review of risk factors for PICC-related complications, the authors listed patient, device, and provider-associated risk factors for PICC-related BSI and venous thromboembolsim (VTE) 26 . Although our registry collected information on a majority of these risk factors (for example, number of prior CVADs, number of PICC lumens, dwell time, monitoring insertion-related complications, infusion of vesicants), we were not able to collect all risk factors found by the review to be significant 26 . The risk factors for non-cancer patients that were unavailable (as they are currently not routinely recored in our EMR) were 1) operative procedure lasting > 1 hour; 2) history of VTE; and 3) PICC diameter/gauge 26 . However, if auto-population of registry variables can be implemented, these could be included in the future registry.
The CVAD registry met the following feasibility criteria: consistency, governance, scope, and clinical meaningful indicators. However, the registry did not meet the criteria for operational requirements, capturing necessary data, and infrastructure. This was due to the difficulty and significant time consumption of locating paper charts after many patients were discharged from the ICU with their PICC. However, it is anticipated that paper charts will eventually be replaced by hospital-wide EMRs due to technology advances in health care settings, thereby rectifying the problem with infrastructure 33 . Additional registry limitations were related to the use of Metavison, which did not contain some of the registry questions as data entry fields (that is to say, PICC inserted on dominant-hand side). Metavision is not yet structured to export http://journals.cambridgepublishing.com.au/sports_journal/Subscribers/Past_Issues/Read_Article?id=735&i=81 7/9
data specifically for CVAD outcomes including CVAD failure, nor to calculate the incidence in CVAD days. This could be solved by adding specific data entry fields to the Metavision platform, enabling registry questions to auto-populate, thus eliminating inefficient manual data entry. Additionally, some Metavision data may have been inaccurate or inconsistent depending on the end users' assessment skills, which requires education on accurate assessment and reporting and resource allocation for such education. However, as registries reflect institutional level performance, such inaccuracies may have little impact on overall findings. Furthermore, Metavision did not allow for correct calculation of CVAD days for patients who had the same PICC over multiple ICU admissions: a problem also encountered in previous studies 34, 35 .
We propose that this limitation may be solved by allocating a unique PICC device number at time of insertion, in order to connect the PICC data between the first and subsequent admissions. However, despite inherent shortcomings, EMRs have been shown to achieve a higher degree of accuracy than manual data collection and also aid in reducing health care-associated infection [36] [37] [38] . For future registry projects to be successful, there is a need for infrastructure of accessible EMRs throughout the episode of care, which would preserve valuable personnel resources 36, 39 .
This study highlighted the inefficiencies of using paper-based charts for registry implementation, as many paper charts were difficult to locate and, in some cases, never found. The EMR was superior for efficient data collection purposes as it could be viewed in multiple locations with instant access. There is a potential to involve multiple hospitals using the same EMR platform to incorporate the registry question fields, thus ensuring ongoing registry participation and inter-institutional, meaningful benchmarking.
The limitations of this registry include: no fields to enter each ward's admission and discharge date and time to specify the location and duration of where the failure and complication occurred; and the loss to follow-up of nearly one-third of patients discharged from the ICU to the ward. The limitations of this study are that it was conducted in only one hospital using one EMR system and the results may not be generalisable to other settings and platforms. In addition, we did not undertake formal timings of data collection workloads. Future registry priorities should include: incorporation of additional fields to enter the admission and discharge date from each ward restructuring of Metavision to auto-populate the registry fields at the point-of-care; and automated reporting of CVAD outcomes such as dwell time, complication and failure rates at the point-of-care. Future use of such registries will provide a valuable archive for clinicians and researchers with an interest in improving CVAD outcomes 2 .
CONCLUSION
In conclusion, this study demonstrated the feasibility of establishing and maintaining a CVAD registry but only in conjunction with hospital-wide EMRs. The adoption of registry fields into the EMR platform will have greater potential for time and cost efficiency by reducing manual data entry and auto-populating the registry at point-ofcare. The increased use of EMRs across different health care settings will promote the development and subsequent increased use of registries. With the increasing emergence of clinical registries in diverse range of fields, more health care stakeholders and clinicians realise the impacts and benefits of registries on patient outcomes and health care costs.
